Menu
Back to Archived Journals » Core Evidence » Volume 2 » Issue 4
Core Evidence ceased publishing in January 2023. All articles that have been published in Core Evidence will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Core Evidence
ISSN: 1555-175X
- View all (143)
- Volume 15, 2020 (4)
- Volume 14, 2019 (6)
- Volume 13, 2018 (3)
- Volume 12, 2017 (2)
- Volume 11, 2016 (5)
- Volume 10, 2015 (9)
- Volume 9, 2014 (13)
- Volume 8, 2013 (7)
- Volume 7, 2012 (12)
- Volume 6, 2011 (7)
- Volume 5, 2010 (9)
- Volume 4, 2009 (20)
- Volume 3, 2008 (5)
- Volume 2, 2007 (22)
- Volume 1-Issues 3 & 4, 2006 (8)
- Volume 1-Issues 1 & 2, 2005 (11)
Archive: Volume 2, 2007
Adalimumab in ankylosing spondylitis: an evidence-based review of its place in therapy
Stephanie Hennigan, Christoph Ackermann, Arthur Kavanaugh
Core Evidence 2007, 2:0-0
Published Date: 15 December 2007
Anidulafungin: an evidence-based review of its use in invasive fungal infections
Susan L. Davis, Jose A. Vazquez
Core Evidence 2007, 2:0-0
Published Date: 15 December 2007
Arzoxifene: the evidence for its development in the management of breast cancer
Lee R. Jackson, Kwok L. Cheung, Aman U. Buzdar, John F. R. Robertson
Core Evidence 2007, 2:0-0
Published Date: 15 December 2007
Paliperidone: the evidence of its therapeutic value in schizophrenia
Joshua Kantrowitz, Leslie Citrome
Core Evidence 2007, 2:0-0
Published Date: 15 December 2007
Ranibizumab: the evidence of its therapeutic value in neovascular age-related macular degeneration
Peter K. Kaiser
Core Evidence 2007, 2:0-0
Published Date: 15 December 2007
Tadalafil: the evidence for its clinical potential in the treatment of pulmonary arterial hypertension
Stuart D. Katz
Core Evidence 2007, 2:0-0
Published Date: 15 December 2007